Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
MEDVF Medivolve
0.050-0.114-69.51%
Close
01/31 16:00 ET
High
0.050
Open
0.050
Turnover
7.65
Low
0.050
Pre Close
0.164
Volume
153.00
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Medivolve to Consolidate Shares on 1-for-15 Basis
Medivolve Reports 1H Results
Medivolve press release (OTCPK:COPRF): 1H net loss was $7.41M in the six months ended June 30, 2022, compared to $18.68M over the prior six months ended June 30, 2021. An increase of 5,056%, cash on
Medivolve reports Q1 results
Medivolve press release (OTCPK:COPRF): Q1 gross profit was $6.41M in the three months ending March 31, 2022, up 518%, compared to $1.05M over the prior three months ending March 31, 2021. Net loss wa
Medivolve reports FY results
Medivolve press release (OTCPK:COPRF): FY Net loss of C$6.61M. Revenue of C$86.82M (+720.6% Y/Y). The Company looks to expand its testing services beyond COVID-19 as COVID infection numbers decrease
Medivolve names Peter Michel as CFO
Medivolve (OTCPK:COPRF) appointed Peter Michel as CFO, effective immediately.Michel will succeed Deborah Battiston.Michel formerly served in leadership roles in both public and private companies with
Medivolve reports Q3 results
Medivolve Inc. (OTCPK:COPRF): Q3 net income was C$6.8M in the third quarter of 2021, compared to a net loss of C$8.7M over the prior three-month period ending June 30, 2021.Revenue of C$25.3M.Press Re
No More
Company Overview
More
Medivolve, Inc. engages in seeking technologies, ground-breaking innovations, and exclusive partnerships to help combat COVID-19 and generate risk-adjusted returns for investors. It offers investors a diversified investment in the COVID-19 medical space across the following areas; prevention, detection, and treatment. The company was founded on November 8, 2005 and is headquartered in Toronto, Canada.
CEO： --
Market： Pink Market
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet